Dynorphin-based "release on demand" gene therapy for drug-resistant temporal lobe epilepsy.
Agostinho AS, Mietzsch M, Zangrandi L, Kmiec I, Mutti A, Kraus L, Fidzinski P, Schneider UC, Holtkamp M, Heilbronn R, Schwarzer C.
Agostinho AS, et al. Among authors: fidzinski p.
EMBO Mol Med. 2019 Oct;11(10):e9963. doi: 10.15252/emmm.201809963. Epub 2019 Sep 5.
EMBO Mol Med. 2019.
PMID: 31486590
Free PMC article.